Metastatic Liver Cancer Global Clinical Trials Review, H1, 2012

GlobalData, January 2012, Pages: 96

Metastatic Liver Cancer Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Metastatic Liver Cancer Global Clinical Trials Review, H1, 2012" provides data on the Metastatic Liver Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Liver Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Liver Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Metastatic Liver Cancer Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Metastatic Liver Cancer , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

List of Tables
List of Figures
Introduction
Metastatic Liver Cancer
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Metastatic Liver Cancer
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Metastatic Liver Cancer Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
Light Sciences Oncology, Inc.
Clinical Trial Overview of Light Sciences Oncology, Inc.
Sirtex Medical Limited
Clinical Trial Overview of Sirtex Medical Limited
NS Pharma, Inc.
Clinical Trial Overview of NS Pharma, Inc.
Gradalis Inc.
Clinical Trial Overview of Gradalis Inc.
Matrix Pharma (Canada) Inc.
Clinical Trial Overview of Matrix Pharma (Canada) Inc.
Micromet AG
Clinical Trial Overview of Micromet AG
AVEO Pharmaceuticals, Inc.
Clinical Trial Overview of AVEO Pharmaceuticals, Inc.
Matrix Pharmaceutical Research
Clinical Trial Overview of Matrix Pharmaceutical Research
Provectus Pharmaceuticals, Inc.
Clinical Trial Overview of Provectus Pharmaceuticals, Inc.
Bayer AG
Clinical Trial Overview of Bayer AG
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Biogen Idec Inc.
Clinical Trial Overview of Biogen Idec Inc.
Celsion Corporation
Clinical Trial Overview of Celsion Corporation
Boston Scientific Corporation
Clinical Trial Overview of Boston Scientific Corporation
Clinical Trial Overview of Top Universities / Institutes / Hospitals
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
University Health Network
Clinical Trial Overview of University Health Network
Radboud University
Clinical Trial Overview of Radboud University
University of Pittsburgh
Clinical Trial Overview of University of Pittsburgh
Massachusetts General Hospital
Clinical Trial Overview of Massachusetts General Hospital
Kyoto University
Clinical Trial Overview of Kyoto University
University of California, San Diego
Clinical Trial Overview of University of California, San Diego
University of Michigan Comprehensive Cancer Center
Clinical Trial Overview of University of Michigan Comprehensive Cancer Center
Samsung Medical Center
Clinical Trial Overview of Samsung Medical Center
University of Heidelberg
Clinical Trial Overview of University of Heidelberg
Aarhus University
Clinical Trial Overview of Aarhus University
European Organization for Research and Treatment of Cancer
Clinical Trial Overview of European Organization for Research and Treatment of Cancer
Kansai Medical University
Clinical Trial Overview of Kansai Medical University
Cancer Prevention Institute of California
Clinical Trial Overview of Cancer Prevention Institute of California
Sidney Kimmel Comprehensive Cancer Center
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
Dana-Farber Cancer Institute
Clinical Trial Overview of Dana-Farber Cancer Institute
Roswell Park Cancer Institute
Clinical Trial Overview of Roswell Park Cancer Institute
Odense University Hospital
Clinical Trial Overview of Odense University Hospital
Royal Marsden Cancer Campaign
Clinical Trial Overview of Royal Marsden Cancer Campaign
University of Michigan
Clinical Trial Overview of University of Michigan
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012-
Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials, BRIC Countries, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials, G7 Countries, 2012-
Metastatic Liver Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials, E7 Countries, 2012-
Metastatic Liver Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012-
Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012-
Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Metastatic Liver Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2012-
Metastatic Liver Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012-
Metastatic Liver Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Light Sciences Oncology, Inc., 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sirtex Medical Limited, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by NS Pharma, Inc., 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Gradalis Inc., 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Matrix Pharma (Canada) Inc., 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Micromet AG, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AVEO Pharmaceuticals, Inc., 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Matrix Pharmaceutical Research, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Provectus Pharmaceuticals, Inc., 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celsion Corporation, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Scientific Corporation, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kansai Medical University, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Prevention Institute of California, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Marsden Cancer Campaign, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2012-

List of Figures
Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012-
Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012-
Metastatic Liver Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials, E7 Countries (%), 2012-
Metastatic Liver Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012-
Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012-
Metastatic Liver Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Metastatic Liver Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
GlobalData Methodology

Customers who bought this item also bought

• Liver Failure Global Clinical Trials Review, H1, 2012
• Liver Cirrhosis Global Clinical Trials Review, H1, 2013
• Fatty Liver Disease Global Clinical Trials Review, H1, 2013
• Cancer Cachexia Global Clinical Trials Review, H1, 2013
• Liver Fibrosis Global Clinical Trials Review, H1, 2013
• Other Metabolic Disorders Global Clinical Trials Review, H1, 2012
• Myelofibrosis Global Clinical Trials Review, H2, 2012
• Osteoporosis Global Clinical Trials Review, H2, 2012
• Cachexia Global Clinical Trials Review, H1, 2013
• Shock Global Clinical Trials Review, H2, 2012